Specialists at the London start-up BenevolentAI helped identify the arthritis drug baricitinib, which is now part of a clinical trial.
Published: April 30, 2020 at 07:12PM
from NYT Technology https://ift.tt/2y4P3bK
Specialists at the London start-up BenevolentAI helped identify the arthritis drug baricitinib, which is now part of a clinical trial.
Published: April 30, 2020 at 07:12PM
from NYT Technology https://ift.tt/2y4P3bK